MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates.

Transgenic mice are increasingly used to probe genetic aspects of cardiovascular pathophysiology. However, the small size and rapid rates of murine hearts make noninvasive, physiological in vivo studies of cardiac bioenergetics and contractility difficult. The aim of this report was to develop an integrated, noninvasive means of studying in vivo murine cardiac metabolism, morphology, and function under physiological conditions by adapting and modifying noninvasive cardiac magnetic resonance imaging (MRI) with image-guided (31)P magnetic resonance spectroscopy techniques used in humans to mice. Using spatially localized, noninvasive (31)P nuclear magnetic resonance spectroscopy and MRI at 4.7 T, we observe mean murine in vivo myocardial phosphocreatine-to-ATP ratios of 2.0 +/- 0.2 and left ventricular ejection fractions of 65 +/- 7% at physiological heart rates ( approximately 600 beats/min). These values in the smallest species studied to date are similar to those reported in normal humans. Although these observations do not confirm a degree of metabolic scaling with body size proposed by prior predictions, they do suggest that mice can serve, at least at this level, as a model for human cardiovascular physiology. Thus it is now possible to noninvasively study in vivo myocardial bioenergetics, morphology, and contractile function in mice under physiological conditions.

[1]  C. Hardy,et al.  Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. , 1990, The New England journal of medicine.

[2]  C J Hardy,et al.  Problems and expediencies in human 31P spectroscopy. The definition of localized volumes, dealing with saturation and the technique‐dependence of quantification , 1989, NMR in biomedicine.

[3]  J. Seidman,et al.  Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.

[4]  R. Griffey,et al.  Myocardial creatine kinase exchange rates and 31P NMR relaxation rates in intact pigs , 1989, Magnetic resonance in medicine.

[5]  B. Lorell,et al.  Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. , 1997, Circulation.

[6]  A. From,et al.  Transmural bioenergetic responses of normal myocardium to high workstates. , 1995, The American journal of physiology.

[7]  C. Hardy,et al.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. , 1991, American heart journal.

[8]  C. Higgins,et al.  Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data. , 1993, Radiology.

[9]  Stefan Neubauer,et al.  Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse , 1998, Magnetic resonance in medicine.

[10]  D. Kass,et al.  Murine cardiac function: a cautionary tail. , 1998, Circulation research.

[11]  H. Yamashita,et al.  ADP inhibits the sliding velocity of fluorescent actin filaments on cardiac and skeletal myosins. , 1994, Circulation research.

[12]  C. Gibbs.  The cytoplasmic phosphorylation potential. Its possible role in the control of myocardial respiration and cardiac contractility. , 1985, Journal of molecular and cellular cardiology.

[13]  K Uğurbil,et al.  31P NMR spectroscopy of the human heart at 4 T: Detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium , 1992, Magnetic resonance in medicine.

[14]  T. Mareci,et al.  Selective fourier transform localization , 1987, Magnetic resonance in medicine.

[15]  R S Balaban,et al.  Relation between work and phosphate metabolite in the in vivo paced mammalian heart. , 1986, Science.

[16]  J. Ingwall,et al.  Creatine kinase system in failing and nonfailing human myocardium. , 1996, Circulation.

[17]  G. Dobson,et al.  Bioenergetic scaling: metabolic design and body-size constraints in mammals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Neubauer,et al.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. , 1997, Circulation.

[19]  Jullie W Pan,et al.  3D 31P Spectroscopic Imaging of the Human Heart at 4.1 T , 1995, Magnetic resonance in medicine.

[20]  J. Ingwall,et al.  Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. , 1998, Circulation research.

[21]  G. Pohost,et al.  Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function. , 1991, The American journal of cardiology.

[22]  P A Bottomley,et al.  Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy. , 1985, Science.

[23]  S. Morikawa,et al.  Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise. , 1994, Circulation.

[24]  J. Seidman,et al.  Diastolic Dysfunction and Altered Energetics in the a MHC 403 / 1 Mouse Model of Familial Hypertrophic Cardiomyopathy , 1998 .

[25]  S. Neubauer,et al.  31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure , 1992, Circulation.

[26]  矢部 隆宏.  Detection of myocardial ischemia by [31]P magnetic resonance spectroscopy during handgrip exercise , 1995 .

[27]  Ronald M Peshock,et al.  Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy. , 1998, American journal of physiology. Heart and circulatory physiology.

[28]  P A Bottomley,et al.  Human cardiac high‐energy phosphate metabolite concentrations by 1D‐resolved NMR spectroscopy , 1996, Magnetic resonance in medicine.